Fibrinogen-Albumin Ratio: An Independent Recurrence Factor for Colorectal Cancer Stages II and III in a Competing Risk Model
FAR is a robust prognostic biomarker for colorectal cancer. Incorporating FAR into clinical practice may enable healthcare providers to more accurately stratify high-risk patients, facilitating personalized treatment strategies.
Authors
- Kiyoshi Sawai
- Mitsuhiro Morikawa
- Kenji Koneri
- Takanori Goi
- Michiaki Shimada
- Masato Tamaki
- Takayuki Tagai
Institutions
- University of Fukui (JP)
Publication Details
- Journal
- Journal of the Anus Rectum and Colon
- Published
- 2025-07-24
- DOI
- https://doi.org/10.23922/jarc.2024-112
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00